Compassionate Use of Pozelimab in Patients With CD55-Deficient Protein-Losing Enteropathy
Clinical trial NCT06003881 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT06003881
- Sponsor
- Regeneron Pharmaceuticals
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.